LifeCell Corporation's portfolio of products includes our well-known soft-tissue repair products for abdominal wall reconstruction, breast reconstruction and breast plastic surgery. Our portfolio began with AlloDerm® Regenerative Tissue Matrix (RTM), which launched in 1994, and expanded with the launch of Strattice™ Reconstructive Tissue Matrix in 2008. In 2012, LifeCell further expanded its portfolio with the launch of AlloDerm® RTM Ready to Use.
In 2011, LifeCell introduced SPY Elite® System into the marketplace. The SPY Elite® system helps surgeons to intraoperatively assess tissue perfusion.
LifeCell™ markets a series of other products for additional applications and procedures, including grafting and ENT/head and neck plastic reconstruction. The company has established relationships with distributors to market products for other applications and procedures throughout the US and in international markets.
Before use, physicians should review all risk information and essential prescribing information which can be found in the Strattice™ Reconstructive Tissue Matrix, AlloDerm® Regenerative Tissue Matrix, and AlloDerm® RTM Ready to Use Instructions for Use.
For complete safety information and complete instructions for the proper use of the SPY Elite® System, please refer to the SPY Elite® System Operator's Manual and SPY Elite® System Kit Instructions for Use. The SPY Elite® System is intended for use as an adjunctive method of assessing tissue perfusion in plastic, reconstructive, micro, gastrointestinal, and cardiovascular surgical procedures. The SPY Elite® System is to be used under the direction of a physician.